Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127035931 | 12703593 | 1 | I | 20151206 | 20160829 | 20160831 | 20160831 | EXP | PHHY2016CN118676 | NOVARTIS | 48.00 | YR | M | Y | 70.00000 | KG | 20160831 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127035931 | 12703593 | 1 | PS | LESCOL | FLUVASTATIN SODIUM | 1 | Oral | 40 MG, QD | 40 | MG | Y | U | X1448 | 20261 | 40 | MG | CAPSULE | QD | |
127035931 | 12703593 | 2 | SS | LESCOL | FLUVASTATIN SODIUM | 1 | 40 | MG | Y | U | 20261 | CAPSULE | |||||||
127035931 | 12703593 | 3 | SS | LESCOL | FLUVASTATIN SODIUM | 1 | 40 | MG | Y | U | 20261 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127035931 | 12703593 | 1 | Coronary artery disease |
127035931 | 12703593 | 2 | Hypertension |
127035931 | 12703593 | 3 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127035931 | 12703593 | HO |
127035931 | 12703593 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127035931 | 12703593 | Chest pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127035931 | 12703593 | 1 | 20151205 | 20151205 | 0 |